DEBx Medical develops DEBRICHEM®, a topical solution that eliminates biofilm and infection in chronic wounds through a single 60-second application. This method significantly reduces treatment time and costs while providing rapid discomfort relief, addressing the challenges of slow healing and the complications associated with traditional debridement methods.
Funding
Funding not disclosed
TCFounders
Product
Problem
Chronic wounds are often plagued by biofilm and infection, which standard debridement methods struggle to eliminate entirely. Traditional treatments can be time-consuming, costly, and may cause discomfort or further tissue damage, leading to slow or incomplete healing.
Solution
DEBx Medical's DEBRICHEM® is a topical solution designed to eradicate biofilm and infection in chronic wounds through a single, 60-second application. This rapid application significantly reduces treatment time and costs compared to traditional debridement. The solution prepares the wound bed for advanced therapies, such as grafts and healing products, facilitating quicker closure of complex wounds. By effectively removing biofilm and infected tissue, DEBRICHEM® promotes a healthier wound environment, reduces the need for extensive procedures, and minimizes patient discomfort. This approach also supports rational antibiotic use, mitigating the risk of antibiotic resistance.
Target Audience
The primary audience includes healthcare professionals such as doctors and nurses specializing in wound care, as well as hospitals and clinics seeking efficient and cost-effective wound treatment solutions.
Features
- Topical solution applied directly to the wound bed
- Rapid 60-second application time
- Effective elimination of biofilm and infection
- Suitable for use in ambulatory settings by doctors and nurses
- No specific training required for application
- Facilitates optimal wound bed preparation for advanced therapies
- Reduces the need for antibiotics